What are the symptoms and treatment options for schistosomiasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms of Schistosomiasis

Schistosomiasis presents with distinct clinical manifestations that vary by infection stage: acute symptoms occur 2-8 weeks after exposure with fever and rash, while chronic disease causes organ-specific symptoms depending on the infecting species—urinary symptoms with S. haematobium and gastrointestinal symptoms with intestinal species. 1

Acute Schistosomiasis (Katayama Syndrome)

Timing and Presentation:

  • Occurs 2-8 weeks after freshwater exposure in newly infected travelers 1
  • Key symptoms include:
    • Fever 1
    • Dry cough 1
    • Urticarial rash 1
    • Diarrhea 1
    • Headache 1
  • Eosinophilia is a key laboratory finding during acute infection 1

Diagnostic Consideration:

  • The combination of eosinophilia with fever and rash after freshwater swimming in endemic areas makes the diagnosis likely even if serology and microscopy are initially negative 1
  • Serology becomes positive at 4-8 weeks post-infection but may take up to 22 weeks 1

Chronic Intestinal Schistosomiasis

Gastrointestinal Manifestations (S. mansoni, S. japonicum, S. intercalatum, S. mekongi):

  • Chronic or intermittent abdominal pain 1
  • Weight loss 1
  • Diarrhea 1
  • Heavy infections can cause:
    • Dysenteric illness 1
    • Intestinal obstruction 1
    • Gastrointestinal bleeding 1

Hepatosplenic Disease:

  • Results from granulomatous inflammation around eggs trapped in liver tissue 2
  • Leads to intrahepatic presinusoidal portal hypertension 3
  • Esophageal and gastric varices are important causes of morbidity and mortality 3

Chronic Urinary Schistosomiasis

Genitourinary Manifestations (S. haematobium):

  • Hematuria (blood in urine) 1
  • Proteinuria 1
  • Dysuria (painful urination) 1
  • Hematospermia (blood in semen) 1
  • Inter-menstrual bleeding in women 1

Diagnostic Approach:

  • Microscopy of nitrocellulose-filtered terminal urine detects eggs 1
  • Urine dipstick for microscopic hematuria and proteinuria has low sensitivity 1

Neuroschistosomiasis

Central Nervous System Involvement:

  • Spinal cord disease (most common with S. mansoni and S. haematobium):

    • Gradual onset paraplegia 1
    • Transverse myelitis 1
    • MRI showing spinal cord enlargement with contrast enhancement 1
  • Cerebral disease (most common with S. japonicum):

    • Focal neurological signs 1
    • Seizures 1
    • Mass lesions on MRI with contrast enhancement 1
    • Altered consciousness in acute cases 1

Diagnostic Challenge:

  • CSF eosinophilia is present in less than 50% of cases 1
  • Serology is often negative 1
  • A trial of treatment may be warranted even with negative serology in suspected cases 1

Chronic Complications

Long-term Sequelae:

  • Fibrosis and calcification at sites of egg entrapment 2
  • Deposition of schistosomal antigen-antibody complexes in renal glomeruli 2
  • Secondary amyloidosis 2
  • Malignancy may complicate chronic lesions in the urinary bladder or colon 2

Co-infections:

  • Salmonella co-infection may confound the clinical picture 4, 2
  • Hepatitis B or C co-infection results in liver disease that progresses more rapidly and is more difficult to treat 3

Diagnostic Workup

Initial Testing:

  • Complete blood count to check for eosinophilia 1
  • Serology for schistosomiasis 1
  • Stool and urine samples for microscopy and/or PCR 1
  • Abdominal ultrasound to assess hepatosplenic involvement and portal hypertension 1

Advanced Imaging:

  • Chest radiograph may show nodules and infiltrates in acute schistosomiasis 1
  • MRI with contrast for suspected neuroschistosomiasis 1

Treatment

Standard Therapy:

  • Praziquantel is the drug of choice for all forms of schistosomiasis 5
  • For S. mansoni, S. intercalatum, and S. guineensis: Praziquantel 40 mg/kg orally as a single dose 5
  • For S. japonicum and S. mekongi: Praziquantel 60 mg/kg orally in two divided doses 5
  • Repeat dose at 6-8 weeks after initial treatment, as immature schistosomules are relatively resistant to initial treatment 5

Acute Schistosomiasis Management:

  • Prednisolone 20-30 mg daily for 5 days to reduce symptom duration 5
  • Praziquantel should be administered after the acute inflammatory phase 5
  • Critical pitfall: Administering praziquantel during acute Katayama syndrome without steroids may worsen symptoms 5

Neuroschistosomiasis:

  • Praziquantel 40 mg/kg twice daily for 5 days 5
  • Combined with dexamethasone 4 mg four times daily, reducing after 7 days, for a total of 2-6 weeks 5
  • In acute neuroschistosomiasis, corticosteroids should be given first, before anthelmintic therapy 5

Important Caveat:

  • Consider potential co-infection with strongyloidiasis before starting corticosteroids, which could precipitate hyperinfection syndrome 5

References

Guideline

Schistosomiasis Diagnosis and Presentation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Human schistosomiasis: clinical perspective: review.

Journal of advanced research, 2013

Research

Gastrointestinal complications of schistosomiasis.

Current gastroenterology reports, 2001

Guideline

Management of Ureteropelvic Junction Obstruction (UPJO) Caused by Schistosomiasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Bilharzia (Schistosomiasis)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.